Ilya Pharma AB – Revolutionising wound care
Globally Spotted is a discovery and social amplification platform for female-led enterprises on a mission to championing more visibility for innovative, smart as well as purpose-driven women-led and founded companies worldwide.
women, entrepreneurs, female entrepreneurs, founders, women-led, women-owned, diversity, visibility, globally spotted
post-template-default,single,single-post,postid-17069,single-format-standard,bridge-core-1.0.4,ajax_fade,page_not_loaded,,qode_grid_1300,side_area_uncovered_from_content,qode-theme-ver-23.2,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-5.7,vc_responsive

Ilya Pharma AB – Revolutionising wound care

Ilya Pharma AB – Revolutionising wound care

Co-Founder & CEO: Evelina Vågesjö
Co-Founder & CSO: Mia Phillipson

Globally Spotted location

Ilya Pharma is developing the next-generation biological drugs for treating wounds in skin and mucosa. The cost effective innovation uses lactic acid bacteria as small bioreactors to produce and deliver human effector proteins on site. This new technology offers a more efficient treatment for healing both acute and chronic wounds.

The unmet clinical need targeted by Ilya Pharma is healing both acute and chronic wounds,  especially problematic for people with diabetes. Indications in the gastrointestinal tract such as irritable bowel disease are also being explored.

Ilya Pharma, founded in 2016, is a spin-out pharmaceutical company with its medical innovation stemming from many years of scientific reasearch at Uppsala University and the Swedish University of Agriculture.